Just a few years ago, Xarelto was being hailed as more than just an up and coming blood thinner. It was the only alternative to Coumadin. For many, it would mean fewer restrictions on their life since Xarelto didn’t require the same blood tests. However, releasing the drug onto the market was an extremely dangerous move taken by Janssen Pharmaceuticals,

Xarelto, one of the newest blood thinners on the market, is under fire. The number of lawsuits against Janssen Pharmaceuticals and Bayer, the manufacturers, have recently increased. There are currently more than 3,000 lawsuits filed against the manufacturers. Lawsuits allege that the manufacturers misled the public and ignored the FDA. Thousands of patients have filed lawsuits alleging excessive bleeding and

As of July 2016, almost 7,000 Xarelto lawsuits were filed against Bayer and Janssen Pharmaceuticals. Xarelto is one of the newest blood thinners out on the market. The problem with Xarelto is found in its side effects. Like other blood thinners, Xarelto carries the risk of uncontrolled bleeding. However, unlike other blood thinners, Xarelto does not have a known antidote

Even more serious than being at risk for a stroke or a blood clot is making a choice between the limited number of blood thinners on the market. Pradaxa, manufactured by Boehringer Ingelheim, is a well-known successor of Coumadin (Warfarin). Although Pradaxa doesn’t require the same weekly blood tests or dietary restrictions as Coumadin, it’s not without its problems. In

Pradaxa is just one of the very few choices available for people who need to take a blood thinner. Many people choose Pradaxa because unlike Coumadin, there is no need for weekly blood work or to follow a special diet. However, Pradaxa is linked to severe bleeding. Pradaxa Caused The Death Of More Than 500 People Pradaxa was approved for